Skip to main content
. 2011 Sep 12;6(9):e24517. doi: 10.1371/journal.pone.0024517

Table 3. ELISpot response rates to any HIV peptide by study visit and study group.

Study group
Total DNA+ rAd5 IM DNA+ rAd5 ID DNA+ rAd5 SC
+/n (%) +/n (%) +/n (%) +/n (%)
Baseline 2/58 (3.4) 1/19 (5.3) 0/18 (0.0) 1/20 (5.0)
2 weeks post DNA series 24/57 (42.1) 8/18 (44.4) 10/20 (50.0) 6/19 (31.6)
4 weeks post rAd5 boost 21/51 (41.2) 7/15 (46.7) 6/17 (35.3) 8/18 (44.4)